• Cao, S., Durrani, F.A. & Rustum, Y.M. (2004) Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clinical Cancer Research, 10, 25612569.
  • Golden, E.B., Lam, P.Y., Kardosh, A., Gaffney, K.J., Cadenas, E., Louie, S.G., Petasis, N.A., Chen, T.C. & Schonthal, A.H. (2009) Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood, 113, 59275937.
  • Goy, A., Bernstein, S.H., Kahl, B.S., Djulbegovic, B., Robertson, M.J., de, V.S., Epner, E., Krishnan, A., Leonard, J.P., Lonial, S., Nasta, S., O’Connor, O.A., Shi, H., Boral, A.L. & Fisher, R.I. (2009) Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study. Annals of Oncology, 20, 520525.
  • Ip, C., Thompson, H.J., Zhu, Z. & Ganther, H.E. (2000) In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Research, 60, 28822886.
  • Juliger, S., Goenaga-Infante, H., Lister, T.A., Fitzgibbon, J. & Joel, S.P. (2007) Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-kappaB inhibition and the rapid generation of other selenium species. Cancer Research, 67, 1098410992.
  • Last, K.W., Cornelius, V., Delves, T., Sieniawska, C., Fitzgibbon, J., Norton, A., Amess, J., Wilson, A., Rohatiner, A.Z. & Lister, T.A. (2003) Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin’s lymphoma. Journal of Clinical Oncology, 21, 23352341.
  • Liu, F.T., Agrawal, S.G., Movasaghi, Z., Wyatt, P.B., Rehman, I.U., Gribben, J.G., Newland, A.C. & Jia, L. (2008) Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib. Blood, 112, 38353846.
  • Obeng, E.A., Carlson, L.M., Gutman, D.M., Harrington, Jr, W.J., Lee, K.P. & Boise, L.H. (2006) Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood, 107, 49074916.
  • Pham, L.V., Tamayo, A.T., Yoshimura, L.C., Lo, P. & Ford, R.J. (2003) Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis. Journal of Immunology, 171, 8895.
  • Wu, Y., Fabritius, M. & Ip, C. (2009) Chemotherapeutic sensitization by endoplasmic reticulum stress: increasing the efficacy of taxane against prostate cancer. Cancer Biology and Therapy, 8, 146152.